What Researchers Did
Researchers retrospectively analyzed ten patients with skull base osteomyelitis treated between 2002 and 2006 to evaluate the value of adjuvant hyperbaric oxygen therapy.
What They Found
Of the ten patients, eight completed therapy, achieving an 8/8 cure rate for inflammatory signs. Functional recovery of cranial nerve deficits was observed in 6/8 patients, while two had residual palsies.
What This Means for Canadian Patients
Canadian patients with skull base osteomyelitis might benefit from adjuvant hyperbaric oxygen therapy as part of their treatment regimen. This approach could potentially improve functional outcomes and reduce inflammatory signs.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's main limitation is its small sample size of ten patients and its retrospective design.